Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial

(2021) Robin K Avery et al.   CLINICAL INFECTIOUS DISEASES

Clinical and Economic Impact of Treated CMV Infection in Adult CMV‐seropositive Patients after Allogeneic Hematopoietic Cell Transplantation

(2020) Régis Peffault De Latour et al.   JOURNAL OF MEDICAL VIROLOGY

Outcomes of transplant recipients treated with cidofovir for resistant or refractory cytomegalovirus infection

(2020) Seema A. Mehta Steinke et al.   Transplant Infectious Disease

Correlation of cytomegalovirus (CMV) disease severity and mortality with CMV viral burden in CMV-seropositive donor and CMV-seronegative solid organ transplant recipients

(2019) Jacqueline M McBride et al.   Open Forum Infectious Diseases

Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection

(2016) Robin K. Avery et al.   TRANSPLANTATION

Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study

(2016) Margaret L Green et al.   Lancet Haematology

CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

(2016) Rafael De la Camara   Mediterranean Journal of Hematology and Infectious Diseases

Cytomegalovirus infection in transplant recipients

(2015) LS Azevedo et al.   Clinics

Cytomegalovirus Serology and Replication Remain Associated With Solid Organ Graft Rejection and Graft Loss in the Era of Prophylactic Treatment

(2014) Martin Stern et al.   TRANSPLANTATION

Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir

(2009) Mark N. Prichard   REVIEWS IN MEDICAL VIROLOGY

Viral Mimicry of Cdc2/Cyclin-Dependent Kinase 1 Mediates Disruption of Nuclear Lamina during Human Cytomegalovirus Nuclear Egress

(2009) Sofia Hamirally et al.   PLoS Pathogens